Last reviewed · How we verify
Licensed varicella vaccine Lot 2
Licensed varicella vaccine Lot 2 is a Biologic drug developed by GlaxoSmithKline. It is currently in Phase 2 development.
At a glance
| Generic name | Licensed varicella vaccine Lot 2 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age (PHASE3)
- A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age (PHASE2)
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age (PHASE3)
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age (PHASE3)
- Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Licensed varicella vaccine Lot 2 CI brief — competitive landscape report
- Licensed varicella vaccine Lot 2 updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Licensed varicella vaccine Lot 2
What is Licensed varicella vaccine Lot 2?
Licensed varicella vaccine Lot 2 is a Biologic drug developed by GlaxoSmithKline.
Who makes Licensed varicella vaccine Lot 2?
Licensed varicella vaccine Lot 2 is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
What development phase is Licensed varicella vaccine Lot 2 in?
Licensed varicella vaccine Lot 2 is in Phase 2.
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Compare: Licensed varicella vaccine Lot 2 vs similar drugs
- Pricing: Licensed varicella vaccine Lot 2 cost, discount & access